Skip to main content

Table 2 Summary odds ratios of emergence agitation and heterogeneity for each direct comparison

From: Effect of ancillary drugs on sevoflurane related emergence agitation in children undergoing ophthalmic surgery: a Bayesian network meta-analysis

Comparison

OR (95% CI)

P-heterogeneity

I-squared

Tau-squared

Dexmedetomidine vs. Placebo

0.26 (0.17, 0.39)

0.697

0.0%

< 0.001

Ketamine vs. Placebo

0.41 (0.20, 0.86)

0.514

0.0%

0.018

Propofol vs. Placebo

0.39 (0.18, 0.83)

–

–

< 0.001

Fentanyl vs. Placebo

0.56 (0.29, 0.89)

–

–

< 0.001

Midazolam vs. Placebo

0.40 (0.21, 0.75)

0.912

0.0%

0.004

Sufentanil vs. Placebo

0.47 (0.38, 0.58)

–

–

< 0.001

Remifentanil vs. Placebo

0.35 (0.17, 0.73)

0.173

46.1%

0.005

Clonidine vs. Placebo

0.29 (0.13, 0.66)

0.399

0.0%

0.003

Ketamine vs. Dexmedetomidine

2.00 (0.46, 8.80)

–

–

0.359

Midazolam vs. Dexmedetomidine

0.97 (0.33, 2.83)

0.126

47.3%

0.851

Clonidine vs. Dexmedetomidine

0.33 (0.03, 3.39)

–

–

0.353

Propofol vs. Ketamine

0.66 (0.30, 1.43)

0.455

0.0%

0.292

Fentanyl vs. Ketamine

0.11 (0.05, 2.09)

–

–

0.140

Midazolam vs. Ketamine

0.73 (0.37, 1.43)

0.159

46.3%

0.360

Midazolam vs. Propofol

0.63 (0.19, 2.07)

–

–

0.443

Sufentanil vs. Fentanyl

0.82 (0.30, 2.26)

–

–

0.699

Clonidine vs. Midazolam

0.96 (0.17, 5.60)

–

–

0.506

  1. P value less than 0.05 is considered as significance with italic fonts